Qualtec Co

Qualtec Co Short-term Debt

The Short-Term Debt of Qualtec Co (9165.T) as of Nov 2, 2026 is 183.05 M JPY. In the previous year, Short-Term Debt was 171.77 M JPY — a change of 6.56% (higher).

Short-term Debt

183.05 MJPY

YoY

6.56%

Last updated:

Short-Term Debt of Qualtec Co is 2026 183.05 M JPY. Short-Term Debt of Qualtec Co was 2025 171.77 M JPY. It decreases by 6.56% higher compared to the previous year.

The Qualtec Co Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2021
244.61 M JPY
Jan 1, 2022
172.05 M JPY
Jan 1, 2023
177.75 M JPY
Jan 1, 2024
164.61 M JPY
Jan 1, 2025
171.77 M JPY
Jan 1, 2026
183.05 M JPY
The Qualtec Co Short-term Debt history
YEARShort-term DebtYoY
183.05 MJPY+6.56%
171.77 MJPY+4.35%
164.61 MJPY-7.39%
177.75 MJPY+3.31%
172.05 MJPY-29.66%
244.61 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

Short-Term Debt of Qualtec Co is 183.05 M JPY in 2026.

Short-Term Debt of Qualtec Co changed from 171.77 M JPY to 183.05 M JPY, representing a 6.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Qualtec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Qualtec Co

All Key Metrics — Qualtec Co